Our Director of Research Dr Sheona Scales describes her four highlights from this year's Clinical Trials on Alzheimer's ...
Needham downgraded Biogen Inc (NASDAQ:BIIB), citing limited catalysts for the company over the next year. Alzheimer’s drug ...
News Medical on MSN17h
Finger-Prick Test Brings Alzheimer’s Detection Closer to EveryoneA new Alzheimer’s test collects just a few drops of blood from a finger prick, which can be mailed to a lab for analysis.
Worldcrunch on MSN21h
Leqembi, Is This New Drug The Turning Point In Curing Alzheimer’s?That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...
Hosted on MSN12h
Ozempic and Viagra, among the more than 80 drugs expected to work against Alzheimer's in the coming yearsToday, the first monoclonal antibodies, lecanemab and donanemab, are available, showing that their reduction effect on these ...
Needham analyst Ami Fadia downgraded Biogen (BIIB) to Hold from Buy.Don't Miss our Black Friday Offers:Discover the latest stocks recommended ...
A view of the new Beijing Stock Exchange at the Financial Street, in Beijing, China, November 15, 2021. REUTERS/Tingshu Wang/File Photo Asian stocks rose on Tuesday while U.S. bond yields and the ...
The US warned Turkey on Monday against hosting Hamas leadership, saying Washington does not believe leaders of a terrorist organization should be living comfortably. Asked about reports that some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback